A detailed history of Algert Global LLC transactions in Insmed Inc stock. As of the latest transaction made, Algert Global LLC holds 81,501 shares of INSM stock, worth $5.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
81,501
Previous 161,375 49.5%
Holding current value
$5.4 Million
Previous $10.8 Million 44.97%
% of portfolio
0.16%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$62.0 - $79.01 $4.95 Million - $6.31 Million
-79,874 Reduced 49.5%
81,501 $5.95 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $1.1 Million - $3.47 Million
49,815 Added 44.65%
161,375 $10.8 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $2.87 Million - $3.34 Million
111,560 New
111,560 $3.03 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $299,187 - $407,903
17,620 New
17,620 $352,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.